This is a heavily interactive web application, and JavaScript is required. Simple HTML interfaces are possible, but that is not what this is.
Post
Newsramp
newsramp.com
did:plc:xlsujlrwr5xpfxgaf4pixhri
Soligenix receives European Commission orphan drug designation for SGX945 in Behçet's disease treatment, validating the company's rare disease pipeline strategy. #Biotech #RareDisease
2026-05-15T04:32:37.572Z